Stem Cells 2021

Feb 26-27, 2021


Online Webinar

Welcome message-

LexisConferences cordially invite you to present your innovative work ideas and interchange ideas in  6th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine to be held from February 26-27, 2021 | Webinar.

Stem cells 2021 present a platform where experts, researchers, professionals and students from across the globe to gather and share their innovative ideas through presentations and oral talk. Conference provides opportunity to enhance and explore knowledge and discuss queries along with challenges in the respective field.

About conference-

Aim- LexisConferences organizing 6th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine webinar will provide a common platform to leaders in research, industrial experts and trainees to share innovative ideas and new visions in respective field leading to development of cutting edge advanced next generation of stem cell technologies such as regenerative medicines.

Why to attend-

Stem cells 2021 will create an ideal platform to share and nutrify knowledge, in-depth learning related to latest research work in stem cells field. Debate to optimize gaps and priorities leading to development of an outstanding next generation stem cell technologies and measure future aspects, updates related to stem cells field. Event provides an opportunity to interact with well renowned speakers and meet industrial experts.

Benefits of attending-

Stem cells 2021 conference brings together experts and trainees to share new visions and innovative ideas. Trainees and students have opportunity to gain in-depth knowledge related to latest research work and have discussion round for any questions.

Target audience-

Keynote speakers, renowned speakers, eminent personalities, association heads, directors, CEO, organization or institution heads, stem cell laboratory heads, researchers, post-doc and students along with companies can be targeted as audience.

Market analysis-

Stem cells market is continuously increasing mainly due to increased awareness regarding researches and therapies along with increased funding from both government and private sectors. The global market of stem cells have CAGR of 36.52% from 2017-2021 and is dominated by USA primarily (13.9% CAGR) followed by Europe (13.4% CAGR). Asia-Pacific show highest growth in stem cells market. North America contributes around 77.45 of total US market.


Stem cells help in fast growth of oncology disorder segment. Research area leading to evolution of new therapies such as regenerative therapies, use of induced pluripotent stem cells as alternative to embryonic stem cells contribute to high revenue share. High totipotency and indefinite lifespan of stem cells are main advantages in market development.

Top companies competing in market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma Aldrich, Becton, Dickinson and company and stem cell technologies.

Dr Alireza Heidari
American International Standards Institute


Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than five hundred reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), Medline/PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Luxembourg, Romania, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Kingdom of Saudi Arabia, Jordan, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international and peer–reviewed journals, books and publishers. Hitherward, he is a member of more than five hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of the American International Standards Institute (AISI), Irvine, California, USA and also Head of Cancer Research Institute (CRI) and Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.

Researches :

  • Cancer Research
Alejandro De La Parra-Solomon
Senior Partner
World Academy of Medical Sciences


Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra serves as COO and Co-founding Partner at The Solomon Brokerage Firm and leads as CEO at Mass Media Division and at De la Parra Mobile Solutions. He is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics. He is the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of Singularity University and of OpenExo.

Researches :

  • Regenerative Medicine

Program Overview

Our Collaborations, Sponsors, Media Partners